Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 44,999 | 48,294 | 43,313 | 38,304 | 33,445 |
| Cost of Goods | 2,088 | 1,785 | 1,286 | 173 | 488 |
| Gross Profit | 42,911 | 46,509 | 42,027 | 38,131 | 32,957 |
| Operating Expenses | 91,846 | 98,532 | 96,001 | 91,079 | 86,702 |
| Operating Income | -48,847 | -51,238 | -53,688 | -52,775 | -53,257 |
| Other Income | 3,764 | 4,479 | 4,107 | 4,213 | 3,648 |
| Pre-tax Income | -45,083 | -46,759 | -49,581 | -48,562 | -49,609 |
| Net Income Continuous | -45,083 | -47,190 | -49,581 | -48,562 | -49,609 |
| Net Income | $-45,083 | $-47,190 | $-49,581 | $-48,562 | $-49,609 |
| EPS Basic Total Ops | -0.52 | -0.54 | -0.58 | -0.57 | -0.60 |
| EPS Basic Continuous Ops | -0.52 | -0.54 | -0.58 | -0.57 | -0.60 |
| EPS Diluted Total Ops | -0.52 | -0.54 | -0.58 | -0.57 | -0.60 |
| EPS Diluted Continuous Ops | -0.52 | -0.54 | -0.58 | -0.57 | -0.60 |
| EPS Diluted Before Non-Recurring Items | -0.52 | -0.54 | -0.58 | -0.57 | -0.60 |
| EBITDA(a) | $-48,397 | $-50,782 | $-53,223 | $-52,204 | $-52,649 |